Cimzia (certolizumab pegol) is a monoclonal antibody that helps the body’s immune system by targeting and destroying certain cells helping to protect healthy cells from damage. Specifically it is a tumor necrosis factor blocker (TNF) for treatment of Crohn’s Disease Rheumatoid Arthritis (RA) Psoriatic Arthritis Ankylosing Spondylitis Non-radiographic Axial Spondylarthritis.
For more information, visit the patient website for this drug.
Speak with your healthcare provider to learn if this drug is right for you.
Biologics (tumor necrosis factor blocker)
WHAT IT TREATS:
Initial dose then two weeks later then 4 weeks and every 4 weeks after
Length of infusion:
About 15 minutes
FOR MORE INFORMATION: